Articles related to Pain Medicine

“Lidocaine is not as safe as we think… there is underreporting. I cannot predict an upper limit of the increase.” – Dr. Michael Fettiplace

Retrospective analysis of more than 1.4 million patients revealed dose-dependent cognitive risks, with younger adults experiencing substantially higher dementia and mild cognitive impairment rates.

Researchers found nonpharmacological approaches achieved 60% patient improvement compared to 30% with medications alone, supporting integrated behavioral health models for fibromyalgia management.

Pain scores decreased from 5.7 to 5.1 on a 10-point scale in moderately stressed participants receiving magnesium supplementation

Joint and muscle pain are established side effects across multiple medication classes including antibiotics, cholesterol-lowering agents, and cancer therapies, with varying onset timing, risk factors, and management approaches that clinicians should recognize to optimize treatment adherence.

“We’ve published several editorials in this past year focused on a 1-year fellowship in a specialty that arguably needs way, way more time, more than 1 year. Are we doing our trainees or even our patients a disservice by continuing that 1-year construct, which is now solidly 30 years old?”